Viewing Study NCT01117103


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-25 @ 4:50 PM
Study NCT ID: NCT01117103
Status: COMPLETED
Last Update Posted: 2014-07-16
First Post: 2010-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2010-05-03
First Submit QC Date: None
Study First Post Date: 2010-05-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-15
Last Update Post Date: 2014-07-16
Last Update Post Date Type: ESTIMATED